RECENT SUCCESSFUL RESEARCH AWARDS:
Published: 3 March 2020
Current successful awards within our school
Professor Pardeep Jhund. 'AZ Statistical Analyses DAPA-HF', Astrazeneca (UK), £76207
Professor Paul Welsh. 'Obesity and cardiovascular disease - UK Biobank' Astrazeneca (UK), £66921
Professor Naveed Sattar. 'BI Consultancy' Boehringer Ingelheim £35880
Professor Naveed Sattar 'Speaker on Expert tour Diabetes NL, EM-0000121725' Boehringer Ingelheim B.V. (Netherland) £9145
Professor Naveed Sattar 'advice on recent scientific disclosures regarding Tirzepatide' Eli Lilly and Company (UK) £1840
Professor Mark Petrie. 'HERMES: Effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation.' Novo Nordisk (UK), £35638
Professor Mark Petrie. 'A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3540378 in Adults with Worsening Chronic Heart Failure with Preserved Ejection Fraction (HFpEF)' Eli Lilly and Company (UK), £33250
Professor Mark Petrie 'The role of SGLT2i in the peri-discharge phase of patients admitted with acute decompensated heart failure' AstraZeneca - Israel £1575
Professor John McMurray 'Member of Data Monitoring for D432500010 study' WCG Clinical, Inc. £24440
Professor John McMurray 'Member of Steering Committee for dal-GenE-2 study' DalCor Pharmaceuticals Canada Inc. £21797
Professor John McMurray 'Provide expert advice related to AZD9977 Dapagliflozin clinical development (CR-028910)' Astrazeneca (UK) £6000
Professor John McMurray 'Develop and support the DAPA-CKD trial publication plan (CR-023797)' Astrazeneca (UK) £3000
Professor Jesse Dawson 'Andexanet alfa development program (CR-028801)' Astrazeneca (SE) £15000
Professor Jesse Dawson 'Andexanet alfa development program (CR-028801)' Medtronic Limited £495
Professor Patrick Mark 'Attendance at Global MK-2060 Ph3 Studies Scientific Input Engagement (14/9/23)' Merck (US) £6000
Professor Colin Berry 'Expertise in the area of cardiology, specifically Chronic Myocardial Ischemic Syndrome.' Liberum Independent Medical Education UK £1500
Professor Colin Berry 'Morbidity of heart failure patients post AMI/STEMI' Radcliffe Group Limited £441
Professor John Cleland '3-stage modified Delphi panel about iron deficiency diagnosis and management in the UK' Vifor Pharma (UK) £1650
First published: 3 March 2020